Here, we show that XRRA1 is a stress-adaptive determinant of radioresponse identified by integrating discovery proteomics into chronic myeloid leukemia with clinical tissue validation and functional studies across multiple tumor models. The gene discussed is XRRA1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.